Optimal Radiation Port Arrangements for Hepatic Tumor using 3-dimensional Conformal Radiotherapy Planning

3차원입체조형방사선치료 계획 시 간종괴의 위치에 따른 최적 조사 방향의 결정

  • Lee, Ik-Jae (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Seong, Jin-Sil (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Shim, Su-Jung (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Jeong, Kyoung-Keun (Department of Radiation Oncology, Yonsei University College of Medicine) ;
  • Cho, Kwang-Hwan (Department of Radiation Oncology, Sunchunhyang University College of Medicine)
  • 이익재 (연세대학교 의과대학 방사선종양학과) ;
  • 성진실 (연세대학교 의과대학 방사선종양학과) ;
  • 심수정 (연세대학교 의과대학 방사선종양학과) ;
  • 정경근 (연세대학교 의과대학 방사선종양학과) ;
  • 조광환 (순천향대학교 의과대학 방사선종양학과)
  • Published : 2006.12.30


The purpose of this study was to investigate the optimal beam arrangements for hepatic tumors, according to the location of the hepatic tumor and its relationship to organs at risk (OARs). The virtual gross tumor volumes were divided into four groups according to the Couinaud's classification. Several plans were made for each virtual target, and these plans were compared for the normal tissue complication probabilities (NTCP). For group I, NTCP improved as the number of the beam ports increased. However, plans with more than 5 ports had little advantage. For group II, plans with the beam directions from the anterior side showed better results. Group III contained many OARs near the target, which placed restrictions on the beam-directions. Multi-directional plans yielded a higher dose to the OARs than a simple two-port plan using right anterior oblique and posterior beam (RAO/PA). For group IV, a simple RAO/PA port plan was adequate for protection of remaining liver. NTCP can significantly vary between radiotherapy plans when the location of the tumor and its neighboring OARs are taken into consideration. The results in this study of optimal beam arrangements could be a useful set of guidelines for radiotherapy of hepatic tumors.


  1. Cochrane AM, Murray-Lyon IM, Brinkley DM, Williams R. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer 1977;40:609-614 https://doi.org/10.1002/1097-0142(197708)40:2<609::AID-CNCR2820400203>3.0.CO;2-L
  2. Ingold JA, Reed GB, Kaplan HS, Bagshaw MA. Radiation Hepatitis. Am J Roentgenol Radium Ther Nucl Med 1965;93:200-208
  3. Lawrence TS, Tesser RJ, ten Haken RK. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 1990;19:1041-1047 https://doi.org/10.1016/0360-3016(90)90031-E
  4. Emami B, Lyman J. Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-122 https://doi.org/10.1016/0360-3016(91)90171-Y
  5. Lawrence TS, Ten Haken RK, Kessler ML, Robertson JM, Lyman JT, Lavigne ML, Brown MB, DuRoss DJ, Andrews JC, Ensminger WD, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992;23:781-788 https://doi.org/10.1016/0360-3016(92)90651-W
  6. Robertson JM, McGinn CJ, Walker S, Marx MV, Kessler ML, Ensminger WD, Lawrence TS. A phase Itrial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Radiat Oncol Biol Phys 1997;39:1087-1092 https://doi.org/10.1016/S0360-3016(97)00550-6
  7. Seong J, Keum KC, Han KH, Lee DY, Lee JT, Chon CY, Moon YM, Suh CO, Kim GE. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 1999;43:393-397 https://doi.org/10.1016/S0360-3016(98)00415-5
  8. Park W, Lim DH, Paik SW, Koh KC, Choi MS, Park CK, Yoo BC, Lee JE, Kang MK, Park YJ, Nam HR, Ahn YC, Huh SJ. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005;61:1143-1150 https://doi.org/10.1016/j.ijrobp.2004.08.028
  9. Shim SJ, Seong J, Han KH, Chon CY, Suh CO, Lee JT. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma. Liver Int 2005;25:1189-1196 https://doi.org/10.1111/j.1478-3231.2005.01170.x
  10. Park JW. Practice guideline for diagnosis and treatment of hepatocellular carcinoma. Korean J Hepatol 2004;10:88-98
  11. Wu DH, Liu L, Chen LH. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2004;10:2184-2189 https://doi.org/10.3748/wjg.v10.i15.2184
  12. Chen LH, Guan J. Evaluation of three-dimensional conformal radiation therapy for small primary hepatocellular carcinoma. Di Yi Jun Yi Da Xue Xue Bao 2003;23:260-261
  13. Seong J, Park HC, Han KH, Chon CY, Chu SS, Kim GE, Sub CO. Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients. Hepatol Res 2003;27:30-35 https://doi.org/10.1016/S1386-6346(03)00162-1
  14. Steadham AM, Liu HH, Crane CH, Janjan NA, Rosen, II. Optimization of beam orientations and weights for coplanar conformal beams in treating pancreatic cancer. Med Dosim 1999;24:265-271 https://doi.org/10.1016/S0958-3947(99)00028-X
  15. Das IJ, Cheng EC, Anderson PR, Movsas B. Optimum beam angles for the conformal treatment of lung cancer: a CT simulation study. Int J Cancer 2000;90:359-365 https://doi.org/10.1002/1097-0215(20001220)90:6<359::AID-IJC8>3.0.CO;2-T
  16. Milecki P, Piotrowski T, Dymnicka M. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field. Neoplasma 2004;51:64-69
  17. Khoo VS, Bedford JL, Webb S, Dearnaley DP. An evaluation of three-field coplanar plans for conformal radiotherapy of prostate cancer. Radiother Oncol 2000;55:31-40 https://doi.org/10.1016/S0167-8140(00)00145-6
  18. Couinaud C. Definition of hepatic anatomical regions and their value during hepatectomy (author's transl.). Chirurgie 1980;106: 103-108
  19. Lyman JT, Wolbarst AB. Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 1987;13:103-109 https://doi.org/10.1016/0360-3016(87)90266-5
  20. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-1630 https://doi.org/10.1016/0360-3016(89)90972-3